GlaxoSmithKline News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

09.01.14	GSK Obtains Accelerated FDA Nod For Combination Use Of Mekinist And Tafinlar (RTTNews)
09.01.14	GSK Receives Accelerated FDA Approval For Combination Use Of Mekinist, Tafinlar (RTTNews)
19.12.13	Skyepharma Eligible For Royalties After Anoro Ellipta's US Approval; Stock Up (RTTNews)
19.12.13	FDA Oks GSK-Theravance's Anoro Ellipta To Treat COPD (RTTNews)
18.12.13	Merck Collaborates With GSK To Evaluate Novel Combination Regimen For Adv RCC (RTTNews)
18.12.13	Oxford BioMedica Inks Option Agreement With GlaxoSmithKline - Quick Facts (RTTNews)
06.12.13	GSK, Theravance Report Positive Results For FF/VI In Late Stage Asthma Study (RTTNews)
06.12.13	GSK, Theravance Report Positive Results From Phase III Study For FF/VI In Asthma (RTTNews)
03.12.13	ACRX At FDA Altar, Orphan Drug Status Lifts CNAT, LCI Moves To NYSE (RTTNews)
27.11.13	Galapagos: GSK2586184 JAK1 Molecule Moves Into Phase 2 For Ulcerative Colitis (RTTNews)
26.11.13	Isis Pharma Begins Phase 1 Trial Of ISIS-GSK3 Rx - Quick Facts (RTTNews)
25.11.13	AMGN, GSK Get FDA Nod, CLDX Walks The Talk, OREX Awaits Light, CELG On A High (RTTNews)
23.11.13	GlaxoSmithKline's N1 Bird Flu Vaccine Gets FDA Approval (RTTNews)
22.11.13	ViiV Healthcare: Tivicay Gets Positive CHMP Opinion In Europe To Treat HIV (RTTNews)
21.11.13	Pfizer, GSK To Collaborate For Phase I/II Study With Palbociclib & Trametinib (RTTNews)
21.11.13	PETX On The Move, IMGN To Pocket $5Mln, RGLS Gets Richer, MYGN Does It Again (RTTNews)
20.11.13	GSK To Sell 28.2 Mln Shares In Aspen Pharmacare - Quick Facts (RTTNews)
19.11.13	GSK Plans To Divest Part Holding In Aspen (RTTNews)
15.11.13	Isis Earns $5 Mln In Milestone Payment From GSK For Advancement Of ISIS-GSK4 Rx (RTTNews)
12.11.13	GSK Reports Top-line Results From Phase III STABILITY Trial Of Darapladib (RTTNews)
30.10.13	GSK Says BREO ELLIPTA Available In U.S. For Treatment Of COPD (RTTNews)
23.10.13	GSK Q3 Profit Declines On Lower Chinese Sales, Backs FY13 Growth View (RTTNews)
23.10.13	GlaxoSmithKline Q3 Pretax Profit Decreases; Affirms FY13 Guidance (RTTNews)
22.10.13	ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV (PR Newswire)
18.10.13	Financial Results, Quarterly Earnings Schedules, Marketing Authorizations, Completed Acquisitions, and New Drug Applications - Research Report on Johnson & Johnson, AbbVie, GSK, AstraZeneca, and Keryx (PR Newswire)
17.10.13	Technical Study: AstraZeneca PLC, GlaxoSmithKline PLC, Keryx Biopharma Inc., and Raptor Pharma Corp. (PR Newswire)
07.10.13	Isis Earns $7 Mln In Milestone Payments From GSK For ISIS-GSK3 Advancement (RTTNews)
04.10.13	Business Strategy, Partnerships, Presentation, and Appointment - Research Report on Merck, GSK, Sanofi, Intercept, and KYTHERA (PR Newswire)
30.09.13	Drug Approvals, Trial Results, and Collaboration- Research Report on Johnson & Johnson, Bristol-Myers Squibb, Eli Lilly, AbbVie, and GSK (PR Newswire)
30.09.13	GSK To Divest Thrombosis Brands, NDB Manufacturing Site For GBP 700 Mln (RTTNews)
30.09.13	GlaxoSmithKline To Sell Thrombosis Brands To Aspen - Quick Facts (RTTNews)
25.09.13	Drug Recommendations, Presentations, Marketing Authorizations, and Board Appointments - Research Report on Johnson & Johnson, Lilly, Sanofi, GSK, and Pacira (PR Newswire)
24.09.13	Critical Alerts For Walter Energy, Celgene, GlaxoSmithKline, UnitedHealth Group, and Safeway Released By InvestorsObserver (PR Newswire)
20.09.13	Conference Call, Presentation of Drug Trial Results, Breakthrough Therapy Designation, Positive Results, and Drug Revival - Research Report on Johnson & Johnson, Lilly, GSK, Kythera, and Sanofi (PR Newswire)
20.09.13	GSK, Prosensa Say Primary Endpoint Not Met In Phase III Study Of Drisapersen (RTTNews)
20.09.13	GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma Treatment (RTTNews)
19.09.13	Technical Scrutiny: GlaxoSmithKline PLC, Keryx Biopharma Inc., AstraZeneca PLC, and Raptor Pharma Corp. (PR Newswire)
19.09.13	Clinical Trial Results, Litigation Outcomes and Marketing Authorizations - Research Report on Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Neurocrine (PR Newswire)
18.09.13	GlaxoSmithKline, Community Care of North Carolina harness "small data" to improve patient care and reduce health care costs (PR Newswire)
18.09.13	Clinical Trial Results, Licensing Agreements, Breakthrough Research and Development Programs - Research Report on Pfizer, Merck, Rockwell Medical, GlaxoSmithKline, and Novartis (PR Newswire)
17.09.13	NDA Updates, Signed Agreements, Awarded Patents, and Clinical Study Results - Research Report on Merck, Bristol-Myers Squibb, Amarin, GlaxoSmithKline, and Sanofi (PR Newswire)
16.09.13	New Drug Applications, FDA Approvals, Approved Acquisitions, Divestitures and Licensing Agreements - Research Report on Merck, Allergan, Mylan, AstraZeneca, and GlaxoSmithKline (PR Newswire)
16.09.13	GSK Granted Priority Review For Dabrafenib/trametinib Combination SNDAs (RTTNews)
13.09.13	New Products, Philanthropic Initiative, Approved Acquisitions, and Pipeline Developments Boost Growth - Research Report on Mylan, UnitedHealth, GSK, Actavis, and Mallinckrodt (PR Newswire)
13.09.13	ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1 (PR Newswire)
11.09.13	FDA Panel Votes In Favor Of Glaxo-Theravance's Lung Drug (RTTNews)
10.09.13	FDA Advisory Committee To Discuss ANORO ELLIPTA; Theravance Stock Halted (RTTNews)
09.09.13	Event, FDA Approval, Positive Results, Partnership, and Marketing Authorization - Research Report on Pfizer, Merck, Bristol-Myers Squibb, Lilly, and GSK (PR Newswire)
09.09.13	GSK To Sell Nutritional Drinks Lucozade, Ribena To Suntory For $2.1 Bln Cash (RTTNews)
06.09.13	Reports: Suntory In Advanced Talks To Buy GlaxoSmithKline's Drink Brands (RTTNews)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.53	0.65 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	77.92	0.39 %	K V
Roche Hldg G	252.10	0.28 %	K V
Part Grp Hldg	1’253.00	0.16 %	K V
CieFinRichemont	121.65	-0.57 %	K V
UBS Group	27.56	-0.72 %	K V
ABB	48.91	-1.27 %	K V
Sika	225.40	-1.40 %	K V
Logitech Intl	70.02	-2.72 %	K V

mehr

27.07.22		GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an
06.06.22		GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten
31.05.22		GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal
27.04.22		GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen
13.04.22		GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent
28.02.22		GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft
10.02.22		CureVac-Aktie steigt: CureVac beginnt Phase-1-Studie mit Grippeimpfstoff-Kandidat
09.02.22		GSK-Aktie gibt dennoch nach: GlaxoSmithKline verdient im Schlussquartal deutlich mehr